Literature DB >> 6647037

Crystal and molecular structure of (E)-5-(2-bromovinyl-2'-deoxyuridine).

L Párkányi, A Kálmán, T Kovács, A Szabolcs, L Otvös.   

Abstract

(E)-5-(2-bromovinyl-2'-deoxyuridine) crystallizes in the space group P2(1) with a = 12.976(1), b = 4.800(1), c = 20.385(2) A, beta = 96.88(1) degrees, Z = (two molecules a and b in the asymmetric unit). The structure has been determined by the use of 2400 diffractometer reflexions and refined by least-squares to R of 0.053. Conformational features of both molecules a and b resemble those of thymidine. The ribofuranose rings assume the rare C(3')-exo form observed also in thymidine. Similarly, the torsion angles around the glycosidic bonds (mean = 40(1) and 56(1) degrees fall in the anti range. In each molecule the best plane of the 2-bromovinyl moiety is bent out of the least-squares plane of the pyrimidine base by 6 degrees, so that the positively charged C(8)-H(8) group can donate an intramolecular hydrogen bond to 0(4) atom. Eight strong and weak intermolecular hydrogen bridges are built up between the symmetry independent and related molecules forming a complicated three dimensional hydrogen bond network.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6647037      PMCID: PMC326554          DOI: 10.1093/nar/11.22.7999

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  5 in total

1.  Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins.

Authors:  Y C Cheng; G Dutschman; E De Clercq; A S Jones; S G Rahim; G Verhelst; R T Walker
Journal:  Mol Pharmacol       Date:  1981-07       Impact factor: 4.436

2.  The crystal structure of deoxyadenosine monohydrate.

Authors:  D G Watson; D J Sutor; P Tollin
Journal:  Acta Crystallogr       Date:  1965-07-10

3.  (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.

Authors:  E De Clercq; J Descamps; P De Somer; P J Barr; A S Jones; R T Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

4.  (E)-5-(2-bromovinyl)-2'-deoxyuridine-5'-triphosphate as a DNA polymerase substrate.

Authors:  J Sági; A Szabolcs; A Szemzö; L Otvös
Journal:  Nucleic Acids Res       Date:  1981-12-21       Impact factor: 16.971

5.  (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.

Authors:  P C Maudgal; E De Clercq; J Descamps; L Missotten; P De Somer; R Busson; H Vanderhaeghe; G Verhelst; R T Walker; A S Jones
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

  5 in total
  2 in total

1.  A comparison of the conformations adopted by some 5-bromovinyl-2'-deoxyuridines and a correlation with their antiviral properties: an X-ray study.

Authors:  L Párkányi; A Kálmán; M Czugler; T Kovács; R T Walker
Journal:  Nucleic Acids Res       Date:  1987-05-26       Impact factor: 16.971

2.  Substrate specificity of DNA polymerases. I. Enzyme-catalysed incorporation of 5-'1-alkenyl)-2'-deoxyuridines into DNA.

Authors:  L Otvös; J Sági; T Kovács; R T Walker
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.